While negotiations are still ongoing on which policy riders (accelerated approval reforms, et. al.) may be included, a senior GOP committee aide confirmed to Endpoints News Thursday that at the very least, an agreement has been reached for the FDA user fee deals, which are good through 2027, to be included in the continuing resolution.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,